CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 25 filers reported holding CLEVELAND BIOLABS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $31,000 | -3.1% | 67,041 | 0.0% | 0.00% | – |
Q2 2014 | $32,000 | -30.4% | 67,041 | 0.0% | 0.00% | – |
Q1 2014 | $46,000 | -44.6% | 67,041 | -6.0% | 0.00% | – |
Q4 2013 | $83,000 | -25.2% | 71,341 | 0.0% | 0.00% | – |
Q3 2013 | $111,000 | -1.8% | 71,341 | 0.0% | 0.00% | – |
Q2 2013 | $113,000 | – | 71,341 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 640,700 | $750,000 | 0.14% |
GOODNOW INVESTMENT GROUP, LLC | 560,461 | $656,000 | 0.11% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 752,038 | $999,000 | 0.03% |
Winfield Associates, Inc. | 15,711 | $18,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 157,249 | $184,000 | 0.01% |
Van Cleef Asset Management,Inc | 20,000 | $23,000 | 0.01% |
ACG Wealth | 31,600 | $37,000 | 0.01% |
KINGS POINT CAPITAL MANAGEMENT | 10,000 | $12,000 | 0.00% |
TAURUS ASSET MANAGEMENT, LLC | 15,000 | $18,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 115,249 | $135,000 | 0.00% |